Last reviewed · How we verify

NCT05753579

Is Regression Possible in Lumbal Disc Herniation With Spinal Mobilization Applications?

Completed NA Last updated 3 March 2023
What this trial tests

NA trial testing Spinal Mobilization in Intervertebral Disc Displacement in 32 participants. Completed in 25 July 2022.

Timeline
18 January 2021
Primary endpoint
25 April 2022
25 July 2022

Quick facts

Lead sponsorMuş Alparslan University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment32
Start date18 January 2021
Primary completion25 April 2022
Estimated completion25 July 2022
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Muş Alparslan University

Who can join

Adults 18 to 65, any sex, with Intervertebral Disc Displacement or Disk Herniated Lumbar. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Spinal mobilization methods are passive maneuvers that are made lighter and do not exceed the physiological range of motion in order to increase joint mobility. Mobilization applications are easier and safer than manipulation applications involving forceful pushing. Although there are many literatures reporting the therapeutic efficacy of long-term mobilization applications on LDH, there is no study on the effect of applications on radiological findings of LDH. In the light of the information mentioned above, the aim of this study is; To examine the effect of mobilization applications on radiological findings and functional level in patients with LDH

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Spinal Mobilization

Trials testing the same drug.

Other recruiting trials for Intervertebral Disc Displacement

Currently open trials in the same condition.

Other Muş Alparslan University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05753579.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing